📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. (2018)

First Author: Bahig H

Attributed to: Development of MRI-guided radiation therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ctro.2018.08.003

PubMed Identifier: 30386824

Publication URI: http://europepmc.org/abstract/MED/30386824

Type: Journal Article/Review

Volume: 13

Parent Publication: Clinical and translational radiation oncology

ISSN: 2405-6308